Abstract:OBJECTIVE:To study the effects of RNA interference (RNAi)-mediated insulin-like growth factor I receptor (IGF-IR) gene silencing on human lung cancer cells. METHODS:Plasmids expressing IGF-IR shRNA1 and IGF-IR shRNA2 were constructed. Human non-small cell lung cancer cells of the line A549 were cultured and transfected with sequence-specific shRNA. RT-PCR was used to monitor the IGF-IR mRNA expression. Western blotting was used to detect the expression of IGF-IR, bcl-2 and caspase-3, associated with apoptosis, and IGF-IR signaling pathways-associated proteins, total and phospho-ERK1/2 and Akt. MTT assay and flow cytometry were used to examine the cell activity and cell cycle. Twelve nude mice were injected subcutaneously with A549 cells, 20 days later the mice were randomly divided into 3 groups to be injected into the tumor with IGF-IR, PBS, or blank plasmid respectively 4 times with the interval of 5 days. Five days after the 4th injection the mice were killed and the tumors were taken out. TUNNEL assay was used to detect the apoptotic cell in the tumor. RESULTS:RT-PCR showed that the IGF-IR mRNA expression level of the A549 cells transfected with IGF-IR shRNA1 was only 24% +/- 4% that of the A549 cells transfected with blank plasmid (P < 0.05); however, the IGF-IR mRNA expression level of the A549 cells transfected with IGF-IR shRNA2 was 78% +/- 5% that of the A549 cells transfected with blank plasmid (P > 0.05). The IGF-IR protein expression level of the A549 cells of the IGF-IR shRNA1 group was only 10.2% +/- 2.8% that of the A549 cells of the blank plasmid group (P < 0.05). Western blotting showed that the protein expression levels of bcl-2 and caspase-3p20 of the A549 cells of the IGF-IR shRNA1 group were 46% +/- 6% and 156% +/- 8% those of the negative controls (both P < 0.05); however, the protein expression levels of bcl-2 and caspase-3p20 of the A549 cells of the IGF-IR shRNA2 group were not different from those of the negative control cells. The Akt kinase and ERK phosphorylation levels of the A549 cells of the IGF-IR shRNA1 group were 10% and 36% +/- 3% those of the negative control cells respectively (both P < 0.05). Since 48h after the transfection the active cell number of the IGF-IR shRNA1 group was 64% +/- 7% that of the negative group (P < 0.05), and this decrease effect lasted to 72 h after (67% +/- 6% that of the negative cells, P < 0.05). 48 h after the transfection the percentage of cells at G(0)/G(1) phase of the IGF-IR shRNA1 group was 77.5%, significantly higher than that of the negative control group, and the percentages of the cells at S and G(2)/M phases of the IGF-IR shRNA1 group were 15.7% and 7.3% respectively, both significantly lower than those of the negative control group (23.0% and 29.9% respectively). Since the second injection the tumor size of the mice of IGF-IR shRNA group was 40% - 50% that of the PBS group (P < 0.05), and the tumor size of the mice of the PBS group was 90% that of the control group. TUNNEL assay showed that the number of apoptotic cells in the tumors of the IGF-IR shRNA1 group mice was 118 +/- 8/high power, significantly higher than that of the control group (70 +/- 9, P < 0.05). CONCLUSION:RNAi technique effectively inhibits the expression of IGF-IR, thus decreasing the NSCLC cell proliferation inducing apoptosis and inhibiting the tumor growth.

The Effects of RNAi Technique and (or) P53 Gene on the Proliferation of Lung Cancer Cells in Vitro

[Effect of siRNA for mutant p53 gene on biological behavior of gastric cancer cell line SGC7901].

The Down-regulation of LINE-1 Encoded ORF-1p Impacts the Characters of A549 Cells

Influences of Over-Expression of VEGF-C and Its Inhibition on Biological Characteristics of NCI-H446 Human Small-Cell Lung Cancer Cells

Study of RNAi Targeting Epidermal Growth Factor Receptor on Lung Adenocarcinoma A549 Cell Line Growth and Sensitivity to Cisplatin

Antitumor Effect of RNA Interference on Non-Small-cell Lung Cancer in Vivo

[The Inhibitory Effects of Sirna Expression Vector on Cell Proliferation and Expression of Hnrnpb1 Gene in Lung Cancer A549 Cells].

Effects of RNAi targeting survivin gene on A549 cell radiosensitivity

In Vitro Investigation of Recombinant Adenovirus-p53 Reversing the Resistance of Non-Small Cell Lung Cancer to Cisplatin

Inhibition of A549 Cell Proliferation by RNA Interfered Gene Her2/neu

[Shrna-Mediated Insulin-Like Growth Factor I Receptor Gene Silencing Inhibits Cell Proliferation, Induces Cell Apoptosis, and Suppresses Tumor Growth in Non-Small Cell Lung Cancer: in Vitro and in Vivo Experiments].

[Effect of Recombinant Adenovirus-P53 on Growth and Chemosensitivity of Human Lung Adenocarcinoma Cell Lines].

Influence of P27RF-Rho gene silencing in proliferation of hepatocelluar carcinoma Bel7402 cells

RNAi Inhibits Bcl-2 Gene Expression and Enhances Radio-Sensitivity of Lung Adenocarcinoma Cell Line A549

Effect of Adenovirus-mediated Wild-Type P53 Gene Transfection on the Growth and Radiosensitivity of Human Lung Adenocarcinoma Cells

Research On The Synergistic Effect Of The Nanoparticle Combined Mirna-451 And Protein On Restraining The Proliferation Of Lung Cancer Cells

Effects of Survivin Interference RNA on Non-Small Cell Lung Carcinoma.

[Effects of Hnrnp B, Sirna on the Expression of P53 in Human Lung Adenocarcinoma Cell Line A549].

Effects of Cyclin G1 Gene Silencing on Proliferation and Apoptosis of Lung Cancer A549 Cells

The Co-Transfection of P16ink4a and P14arf Genes into Human Lung Cancer Cell Line A549 and the Effects on Cell Growth and Chemosensitivity

Effect of targeting inhibition of epidermal growth factor receptor expression by RNA interference on the proliferation of colon cancer cells